Basics Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system. IPO Date: November 19, 2015 Sector: Healthcare Industry: Biotech Market Cap: $5.01B Activated in VL: True Average Daily Range Avg Daily Range: $1.13 | 2.99% Avg Daily Range (30 D): $1.52 | 1.43% Avg Daily Range (90 D): $1.91 | 1.68% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .51M Avg Daily Volume (90 D): .66M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 38 Avg Trade Size (Sh.) (90 D): 42 Institutional Trades Total Inst.Trades: 3,248 Avg Inst. Trade: $2.88M Avg Inst. Trade (30 D): $5.86M Avg Inst. Trade (90 D): $5.96M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.56M Avg Closing Trade (30 D): $7.75M Avg Closing Trade (90 D): $8.63M Avg Closing Volume: 53.03K     News Jun 20, 2025 @ 11:00 AM Axsome Therapeutics Champions Brain Health During ... Source: N/A Jun 11, 2025 @ 11:00 AM Axsome Therapeutics Showcases Innovation in Sleep ... Source: Axsome Therapeutics Jun 5, 2025 @ 7:19 AM 2 Soaring Stocks Wth More Upside Potential Source: Prosper Junior Bakiny Jun 4, 2025 @ 11:00 PM Investor Alert: Class Action Lawsuits Against Gene... Source: Johnson Fistel, Pllp May 29, 2025 @ 11:00 AM Axsome Therapeutics to Participate in Upcoming Inv... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-5.77 $-1.22 $-1.54 Diluted EPS $-5.77 $-1.22 $-1.54 Revenue $ 432.16M $ 121.46M $ 118.77M Gross Profit $ $ $ Net Income / Loss $ -278.27M $ -59.41M $ -74.91M Operating Income / Loss $ -270.27M $ -56.98M $ -72.62M Cost of Revenue $ $ $ Net Cash Flow $ -30.53M $ -14.44M $ -11.99M PE Ratio